CEACAM5 antibody-drug conjugate formulations
The present invention provides stable formulations of human carcino-embryonic antigen related cell adhesion molecule 5 (hCEACAM5)-targeted antibody-drug conjugate huMAb2-3-SPDB-DM4, as well as methods of making and using the same. 本发明提供人类癌胚抗原相关细胞黏附分子5(hCEACAM5)-标靶抗体-药物缀合物huMAb2-3-SPDB-DM4的稳定制剂,及其制备和...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention provides stable formulations of human carcino-embryonic antigen related cell adhesion molecule 5 (hCEACAM5)-targeted antibody-drug conjugate huMAb2-3-SPDB-DM4, as well as methods of making and using the same.
本发明提供人类癌胚抗原相关细胞黏附分子5(hCEACAM5)-标靶抗体-药物缀合物huMAb2-3-SPDB-DM4的稳定制剂,及其制备和使用方法。 |
---|